These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 38092186)

  • 1. Systemic treatment with ubiquitin carboxy terminal hydrolase L1 TAT protein ameliorates axonal injury and reduces functional deficits after traumatic brain injury in mice.
    Mi Z; Ma J; Zeh DJ; Rose ME; Henchir JJ; Liu H; Ma X; Cao G; Dixon CE; Graham SH
    Exp Neurol; 2024 Mar; 373():114650. PubMed ID: 38092186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abolishing UCHL1's hydrolase activity exacerbates TBI-induced axonal injury and neuronal death in mice.
    Mi Z; Liu H; Rose ME; Ma X; Reay DP; Ma J; Henchir J; Dixon CE; Graham SH
    Exp Neurol; 2021 Feb; 336():113524. PubMed ID: 33159930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation of a Ubiquitin Carboxy Terminal Hydrolase L1 Lipid Binding Site Alleviates Cell Death, Axonal Injury, and Behavioral Deficits After Traumatic Brain Injury in Mice.
    Mi Z; Liu H; Rose ME; Ma J; Reay DP; Ma X; Henchir JJ; Dixon CE; Graham SH
    Neuroscience; 2021 Nov; 475():127-136. PubMed ID: 34508847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo transduction of neurons with TAT-UCH-L1 protects brain against controlled cortical impact injury.
    Liu H; Rose ME; Ma X; Culver S; Dixon CE; Graham SH
    PLoS One; 2017; 12(5):e0178049. PubMed ID: 28542502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of UCHL1 in axonal injury and functional recovery after cerebral ischemia.
    Liu H; Povysheva N; Rose ME; Mi Z; Banton JS; Li W; Chen F; Reay DP; Barrionuevo G; Zhang F; Graham SH
    Proc Natl Acad Sci U S A; 2019 Mar; 116(10):4643-4650. PubMed ID: 30760601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abolishing UCHL1's hydrolase activity exacerbates ischemia-induced axonal injury and functional deficits in mice.
    Mi Z; Povysheva N; Rose ME; Ma J; Zeh DJ; Harikumar N; Bhuiyan MIH; Graham SH
    J Cereb Blood Flow Metab; 2024 Jun; ():271678X241258809. PubMed ID: 38833565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The point mutation UCH-L1 C152A protects primary neurons against cyclopentenone prostaglandin-induced cytotoxicity: implications for post-ischemic neuronal injury.
    Liu H; Li W; Rose ME; Hickey RW; Chen J; Uechi GT; Balasubramani M; Day BW; Patel KV; Graham SH
    Cell Death Dis; 2015 Nov; 6(11):e1966. PubMed ID: 26539913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin Does Not Alter Serum Profiles of Neuronal and Axonal Biomarkers After Traumatic Brain Injury: Findings From the Australian EPO-TBI Clinical Trial.
    Hellewell SC; Mondello S; Conquest A; Shaw G; Madorsky I; Deng JV; Little L; Kobeissy F; Bye N; Bellomo R; Cooper DJ; Vallance S; Board J; Morganti-Kossmann MC
    Crit Care Med; 2018 Apr; 46(4):554-561. PubMed ID: 29278529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EPPS treatment attenuates traumatic brain injury in mice by reducing Aβ burden and ameliorating neuronal autophagic flux.
    Anthony Jalin AMA; Jin R; Wang M; Li G
    Exp Neurol; 2019 Apr; 314():20-33. PubMed ID: 30639321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ubiquitin carboxy-terminal hydrolase L1 - physiology and pathology.
    Matuszczak E; Tylicka M; Komarowska MD; Debek W; Hermanowicz A
    Cell Biochem Funct; 2020 Jul; 38(5):533-540. PubMed ID: 32207552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated serum ubiquitin carboxy-terminal hydrolase L1 is associated with abnormal blood-brain barrier function after traumatic brain injury.
    Blyth BJ; Farahvar A; He H; Nayak A; Yang C; Shaw G; Bazarian JJ
    J Neurotrauma; 2011 Dec; 28(12):2453-62. PubMed ID: 21428722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of UCHL1 in the pathogenesis of neurodegenerative diseases and brain injury.
    Mi Z; Graham SH
    Ageing Res Rev; 2023 Apr; 86():101856. PubMed ID: 36681249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ubiquitin C-terminal hydrolase L1 deletion ameliorates glomerular injury in mice with ACTN4-associated focal segmental glomerulosclerosis.
    Read NC; Gutsol A; Holterman CE; Carter A; Coulombe J; Gray DA; Kennedy CR
    Biochim Biophys Acta; 2014 Jul; 1842(7):1028-40. PubMed ID: 24662305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperfiltration in ubiquitin C-terminal hydrolase L1-deleted mice.
    Boisvert NC; Holterman CE; Thibodeau JF; Nasrallah R; Kamto E; Comin CH; Costa LDF; Carter A; Hébert RL; Gutsol A; Cron GO; Lacoste B; Gray DA; Kennedy CR
    Clin Sci (Lond); 2018 Jul; 132(13):1453-1470. PubMed ID: 29739827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ubiquitin carboxyl-terminal hydrolase L1, a novel deubiquitinating enzyme in the vasculature, attenuates NF-kappaB activation.
    Takami Y; Nakagami H; Morishita R; Katsuya T; Cui TX; Ichikawa T; Saito Y; Hayashi H; Kikuchi Y; Nishikawa T; Baba Y; Yasuda O; Rakugi H; Ogihara T; Kaneda Y
    Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2184-90. PubMed ID: 17690318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. cPKCγ-mediated down-regulation of UCHL1 alleviates ischaemic neuronal injuries by decreasing autophagy via ERK-mTOR pathway.
    Zhang D; Han S; Wang S; Luo Y; Zhao L; Li J
    J Cell Mol Med; 2017 Dec; 21(12):3641-3657. PubMed ID: 28726275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of BACE1 degradation and APP processing by ubiquitin carboxyl-terminal hydrolase L1.
    Zhang M; Deng Y; Luo Y; Zhang S; Zou H; Cai F; Wada K; Song W
    J Neurochem; 2012 Mar; 120(6):1129-38. PubMed ID: 22212137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recessive loss of function of the neuronal ubiquitin hydrolase UCHL1 leads to early-onset progressive neurodegeneration.
    Bilguvar K; Tyagi NK; Ozkara C; Tuysuz B; Bakircioglu M; Choi M; Delil S; Caglayan AO; Baranoski JF; Erturk O; Yalcinkaya C; Karacorlu M; Dincer A; Johnson MH; Mane S; Chandra SS; Louvi A; Boggon TJ; Lifton RP; Horwich AL; Gunel M
    Proc Natl Acad Sci U S A; 2013 Feb; 110(9):3489-94. PubMed ID: 23359680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progesterone Treatment Does Not Decrease Serum Levels of Biomarkers of Glial and Neuronal Cell Injury in Moderate and Severe Traumatic Brain Injury Subjects: A Secondary Analysis of the Progesterone for Traumatic Brain Injury, Experimental Clinical Treatment (ProTECT) III Trial.
    Korley F; Pauls Q; Yeatts SD; Jones CMC; Corbett-Valade E; Silbergleit R; Frankel M; Barsan W; Cahill ND; Bazarian JJ; Wright DW
    J Neurotrauma; 2021 Jul; 38(14):1953-1960. PubMed ID: 33319651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ubiquitin C-terminal hydrolase L1 is required for pancreatic beta cell survival and function in lipotoxic conditions.
    Chu KY; Li H; Wada K; Johnson JD
    Diabetologia; 2012 Jan; 55(1):128-40. PubMed ID: 22038515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.